GlassScriptPhysician profile
Harvey MD Patel
NPI 1245898923
$1,814.43
in general payments reported to CMS, 2019-2025
9 companies · $865 in 2025
The $865 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $312 · 2024: $638 · 2025: $865.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,744 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,744.44 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $865.60 | 2023-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $344.81 | 2023-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $161.52 | 2024-2025 | Lumryz |
| Axsome Therapeutics, INC. | $156.44 | 2025 | Sunosi |
| Teva Pharmaceuticals USA, INC. | $112.49 | 2023 | Austedo Xr |
| Idorsia Pharmaceuticals US INC | $67.56 | 2023-2024 | Quviviq |
| Fisher & Paykel Healthcare INC | $54.37 | 2024-2025 | Fisher & Paykel Healthcare |
| Zoll Respicardia, INC. | $34.50 | 2024 | Remede System |
| Azurity Pharmaceuticals, INC. | $17.14 | 2024 | Horizant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harvey Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.